2.
GN方案在晚期NSCLC的二线及二线以上治疗的短期疗效比较
Short-term efficacy of GN regimen as second-line or further-line therapy for patients with advanced NSCLC
Best response | Second-line (n=28) | Third-line (n=25) |
CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; ORR: objective response rate; DCR: disease control rate; NSCLC: non-small cell lung cancer. | ||
CR | 0 | 0 |
PR | 3 | 2 |
SD | 13 | 11 |
PD | 12 | 12 |
ORR | 10.7% | 7.1% |
DCR | 57.1% | 52.0% |